Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 95

Similar articles for PubMed (Select 24128675)

1.

Abnormal gephyrin immunoreactivity associated with Alzheimer disease pathologic changes.

Hales CM, Rees H, Seyfried NT, Dammer EB, Duong DM, Gearing M, Montine TJ, Troncoso JC, Thambisetty M, Levey AI, Lah JJ, Wingo TS.

J Neuropathol Exp Neurol. 2013 Nov;72(11):1009-15. doi: 10.1097/01.jnen.0000435847.59828.db.

2.

Regional distribution of TDP-43 inclusions in Alzheimer disease (AD) brains: their relation to AD common pathology.

Kadokura A, Yamazaki T, Lemere CA, Takatama M, Okamoto K.

Neuropathology. 2009 Oct;29(5):566-73. doi: 10.1111/j.1440-1789.2009.01017.x. Epub 2009 Apr 21.

PMID:
19422539
3.

Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis.

Bloom GS.

JAMA Neurol. 2014 Apr;71(4):505-8. doi: 10.1001/jamaneurol.2013.5847. Review.

PMID:
24493463
4.

Correlation analysis of capillary APOE, VEGF and eNOS expression in Alzheimer brains.

Provias J, Jeynes B.

Curr Alzheimer Res. 2011 Mar;8(2):197-202.

PMID:
21143177
5.

α7 Nicotinic receptor agonist enhances cognition in aged 3xTg-AD mice with robust plaques and tangles.

Medeiros R, Castello NA, Cheng D, Kitazawa M, Baglietto-Vargas D, Green KN, Esbenshade TA, Bitner RS, Decker MW, LaFerla FM.

Am J Pathol. 2014 Feb;184(2):520-9. doi: 10.1016/j.ajpath.2013.10.010. Epub 2013 Nov 19.

6.

Non-Alzheimer neurodegenerative pathologies and their combinations are more frequent than commonly believed in the elderly brain: a community-based autopsy series.

Kovacs GG, Milenkovic I, Wöhrer A, Höftberger R, Gelpi E, Haberler C, Hönigschnabl S, Reiner-Concin A, Heinzl H, Jungwirth S, Krampla W, Fischer P, Budka H.

Acta Neuropathol. 2013 Sep;126(3):365-84. doi: 10.1007/s00401-013-1157-y. Epub 2013 Jul 31.

PMID:
23900711
7.

Neuropathological changes in aging brain.

Xekardaki A, Kövari E, Gold G, Papadimitropoulou A, Giacobini E, Herrmann F, Giannakopoulos P, Bouras C.

Adv Exp Med Biol. 2015;821:11-7. doi: 10.1007/978-3-319-08939-3_6. Review.

PMID:
25416106
8.

Reduced expression of the inhibitory synapse scaffolding protein gephyrin in Alzheimer's disease.

Agarwal S, Tannenberg RK, Dodd PR.

J Alzheimers Dis. 2008 Jul;14(3):313-21.

PMID:
18599957
10.

[The pathophysiology of Alzheimer's disease with special reference to "amyloid cascade hypothesis"].

Tamaoka A.

Rinsho Byori. 2013 Nov;61(11):1060-9. Review. Japanese.

PMID:
24450113
11.

Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease.

Lue LF, Kuo YM, Roher AE, Brachova L, Shen Y, Sue L, Beach T, Kurth JH, Rydel RE, Rogers J.

Am J Pathol. 1999 Sep;155(3):853-62.

12.

Abeta solubility and deposition during AD progression and in APPxPS-1 knock-in mice.

Murphy MP, Beckett TL, Ding Q, Patel E, Markesbery WR, St Clair DK, LeVine H 3rd, Keller JN.

Neurobiol Dis. 2007 Sep;27(3):301-11. Epub 2007 Jun 12.

PMID:
17651976
13.

Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.

Berg L, McKeel DW Jr, Miller JP, Storandt M, Rubin EH, Morris JC, Baty J, Coats M, Norton J, Goate AM, Price JL, Gearing M, Mirra SS, Saunders AM.

Arch Neurol. 1998 Mar;55(3):326-35.

PMID:
9520006
14.

Individual severity of AD-type lesions, Aß oligomers, and comorbidity in the brain aging.

Bouras C, Kovari E, Savioz A, Giacobini E, Xekardaki A.

Adv Exp Med Biol. 2015;822:17. doi: 10.1007/978-3-319-08927-0_4. No abstract available.

PMID:
25416972
15.

[The role of cholesterol in Alzheimer's neuro-pathogenesis].

Biondi E.

Riv Biol. 2006 May-Aug;99(2):210-5. Review. Italian.

PMID:
17115369
16.

Clinicopathologic correlations in a large Alzheimer disease center autopsy cohort: neuritic plaques and neurofibrillary tangles "do count" when staging disease severity.

Nelson PT, Jicha GA, Schmitt FA, Liu H, Davis DG, Mendiondo MS, Abner EL, Markesbery WR.

J Neuropathol Exp Neurol. 2007 Dec;66(12):1136-46.

17.

Mechanisms of neurofibrillary degeneration and the formation of neurofibrillary tangles.

Iqbal K, Alonso AC, Gong CX, Khatoon S, Pei JJ, Wang JZ, Grundke-Iqbal I.

J Neural Transm Suppl. 1998;53:169-80. Review.

PMID:
9700655
18.

Activation of caspase-6 in aging and mild cognitive impairment.

Albrecht S, Bourdeau M, Bennett D, Mufson EJ, Bhattacharjee M, LeBlanc AC.

Am J Pathol. 2007 Apr;170(4):1200-9.

19.
20.

Involvement of WAVE accumulation in Abeta/APP pathology-dependent tangle modification in Alzheimer's disease.

Takata K, Kitamura Y, Nakata Y, Matsuoka Y, Tomimoto H, Taniguchi T, Shimohama S.

Am J Pathol. 2009 Jul;175(1):17-24. doi: 10.2353/ajpath.2009.080908. Epub 2009 Jun 4.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk